Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World Data.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy.
Journal: Cancers
Published: March 18, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.
Journal: Cancer research communications
Published: January 20, 2026
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.
Journal: Blood cancer journal
Published: November 03, 2025
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.
Journal: Blood reviews
Published: July 25, 2025
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.
Journal: British journal of haematology
Published: July 18, 2025
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 24, 2025
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody.
Journal: Blood reviews
Published: December 05, 2024
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.
Journal: British journal of haematology
Published: November 04, 2019
Last Updated: 09/26/2026